SeaLife Pharma

Technopark 1 / Gebäude C
3430 Tulln

+43 2272 62606

SeaLife Pharma is a leading marine biopharma company pioneering the discovery and development of novel biochemistry isolated from the under-explored biological diversity of marine fungi. Our core focus is to develop novel antibiotics to treat multi-drug resistant Gram negative and Gram positive infections based on clinical isolates e.g. Pseudomonas aeruginosa, Acinetobacter baumannii, Penicillin resistant Streptococci pneumoniae (PRSP), MRSA and Vancomycin resistant enterococci (VRE). 

The company is located at the Technology and Research Center in Tulln and keeps a 600m² facility including laboratories for biological (security level 2) and toxicological screening, chemical synthesis and chemical analytics.

Contact: Alexander Pretsch